2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Status
Completed
3
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Other
2
Endocrine
1
Conditions
Motor Activity
32
Breast Neoplasms
21
Neoplasms
17
Prostatic Neoplasms
11
Obesity
8
Sarcopenia
6
Colorectal Neoplasms
6
Pancreatic Neoplasms
5
Lung Neoplasms
5
Head and Neck Neoplasms
5
Polycystic Ovary Syndrome
4
Signs and Symptoms
3
Multiple Myeloma
3
Lymphedema
3
Inflammation
3
Fatigue
3
Diabetes Mellitus, Type 2
3
Colonic Neoplasms
3
Brain Neoplasms
3
Uterine Cervical Neoplasms
2
Pharyngeal Neoplasms
2
Overweight
2
Osteoporosis, Postmenopausal
2
Osteoporosis
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Laryngeal Neoplasms
2
Insulin Resistance
2
Hematopoietic and Lymphatic System Neoplasm
2
Interventions
relacorilant
5
Metformin
5
Pioglitazone
4
Dipeptidyl-Peptidase IV Inhibitors
4
Sulfonylurea Compounds
3
Sitagliptin Phosphate
3
Resistance Training
3
saxagliptin
2
Vildagliptin
2
Sodium-Glucose Transporter 2 Inhibitors
2
Rosiglitazone
2
Nutritional Status
2
Glucagon-Like Peptide-1 Receptor Agonists
2
Blood Specimen Collection
2
voglibose
1
somapacitan
1
semaglutide
1
repaglinide
1
pembrolizumab
1
miglitol
1
metahexamide
1
meglitinide
1
mazdutide
1
glymidine
1
glisoxepide
1
gliquidone
1
glimepiride
1
glibornuride
1
empagliflozin
1
desaminopancreozymin octapeptide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Diabetes Mellitus, Type 2
×
Resistance Training
×
Clear all
NCT00786019
2023-07-12
InsITE
University of Colorado, Denver
Phase NA
Completed
47 enrolled
22 charts
NCT00697580
2017-03-31
SANO LA
University of Southern California
Phase NA
Completed
104 enrolled
NCT01441323
2017-03-31
STAND
University of Southern California
Phase NA
Completed
62 enrolled